CONMED Income Statement Analysis

Revenue, earnings, and profit margins in billions USD

Scroll to see more
CONMED Corporation income statement - Annual data in billions USD
BreakdownFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018
Period EndingDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018
Revenue & Gross Profit
Revenue1.371.311.241.051.010.860.960.86
Cost of Revenue0.590.570.570.470.440.400.430.39
Gross Profit0.790.730.680.570.570.460.520.47
Operating Expenses
Research & Development0.060.050.050.050.040.040.050.04
Selling, General & Administrative0.540.520.500.450.410.370.400.36
Operating Expenses0.590.570.560.500.460.410.450.40
Operating Income0.190.160.120.070.110.050.080.07
Other Income/Expense
Interest Income0.000.000.000.000.000.000.000.00
Interest Expense-0.03-0.04-0.040.03-0.04-0.040.000.02
Other Income/Expense0.00-0.04-0.01-0.110.000.000.010.00
Income
Income Before Tax0.070.160.08-0.070.070.000.030.05
Income Tax Expense0.020.030.020.010.01-0.010.000.01
Net Income0.050.130.06-0.080.060.010.030.04
Net Income - Continuous Operations0.000.130.06-0.080.060.000.000.00
Net Income - Discontinued Operations0.000.000.000.000.000.000.000.00
EBITDA0.260.230.200.030.180.120.160.13
EBIT0.190.160.12-0.040.110.050.070.07
Depreciation & Amortization0.070.070.070.070.070.070.000.00
Earnings Per Share
Basic EPS2.004.002.00-3.002.00-1.001.00
Diluted EPS2.004.002.00-3.002.00-1.001.00
Basic Shares Outstanding0.030.030.030.030.030.030.030.03
Diluted Shares Outstanding0.030.030.030.030.030.030.030.03